Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Shareholder feedback

and I quote "And with only 20mio/year coming from the MMP (see Cohen report) we will have tremendous problems to finance interesting objectives for our M&A in the next years." end quote.

I disagree. 3 to 9 million from Crossflo in 2009 will help. WIth everything. Hopefully that 3 to 9 will be a nice and steady stream.

And toss in a favorable uspto ruling, that will hopefully come soon, will help everything.

Guess I'm more optimistic or is it the rose colored glasses that are talking.

Share
New Message
Please login to post a reply